Once daily vs. twice daily applications of topical treatments in psoriasis [15]

British Journal of Dermatology

Volumn 153, Issue 6, 2005, Pages 1245-

  Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL;

CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIASIS VULGARIS; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

BETAMETHASONE; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; HUMANS; PSORIASIS;

EID: 28844495421     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06972.x     Document Type: Letter

References (3)

1. van de Kerkhof PCM. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet®/Dovobet®) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial. Br J Dermatol 2004; 151:663-8.
2. Zaghloul SS, Goodfield MJD. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 139:408-14.
3. van de Kerkhof PCM, de Hoop D, de Korte J et al. Patient compliance in the treatment of psoriasis. Dermatology 2000; 200:292-8.